LONDON, England, September 26 /PRNewswire/ -- Constant improvements in instrument capabilities and broad test menus are driving the immunodiagnostics automation markets across Europe. While the wide range of integrated analysers has significantly improved profitability and revenue returns, declining reimbursement rates and the lack of common industry standards for immunodiagnostic tests will hinder market expansion. This situation will compel in vitro diagnostics (IVD) manufacturers to design innovative strategies.
